Manon Belhassen

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study.

Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study.

Journal: Journal of comparative effectiveness research

Published: March 23, 2026

Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulators.

Effect of discontinuation and reduction of respiratory cotherapies on the effectiveness of CFTR modulators.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: February 10, 2026

ADHERENCE PATTERNS AND THEIR DETERMINANTS TO CFTR MODULATORS IN FRANCE.

ADHERENCE PATTERNS AND THEIR DETERMINANTS TO CFTR MODULATORS IN FRANCE.

Journal: Respiratory medicine

Published: December 19, 2025

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study.

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study.

Journal: Journal of bone oncology

Published: December 12, 2025

Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012 to 2020.

Medication adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: Analysis on the French cystic fibrosis population from 2012 to 2020.

Journal: Respiratory medicine

Published: October 01, 2025

Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France.

Nationwide extrapolation of economic benefit of therapeutic innovation: a 10-year retrospective budget impact of direct oral anticoagulants introduction in France.

Journal: Journal of medical economics

Published: June 06, 2025

Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patients.

Use of supplemental oxygen therapy in idiopathic pulmonary fibrosis: an observational real-life study in 16 003 patients.

Journal: BMJ open respiratory research

Published: January 10, 2025

Epidemiology of bone metastasis in France between 2009 and 2018.

Epidemiology of bone metastasis in France between 2009 and 2018.

Journal: JBMR plus

Published: December 30, 2024

Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.

Newborn Screening for Cystic Fibrosis Is Associated With the Lowest Healthcare Costs: A 10-Year Observational Follow-Up Study in France.

Journal: Pediatric pulmonology

Published: November 12, 2024

Are Healthcare Resource Utilization Patterns for Pain Management Specific to Post-Acute COVID-19 Syndrome? A Study of Survivors from the First French Pandemic Wave.

Are Healthcare Resource Utilization Patterns for Pain Management Specific to Post-Acute COVID-19 Syndrome? A Study of Survivors from the First French Pandemic Wave.

Journal: Journal of clinical medicine

Published: November 11, 2024

Management of patients with active relapsing-remitting or secondary progressive multiple sclerosis: A French real-world study based on claims data linked to a phase IV study.

Management of patients with active relapsing-remitting or secondary progressive multiple sclerosis: A French real-world study based on claims data linked to a phase IV study.

Journal: Multiple sclerosis and related disorders

Published: October 29, 2024

Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2021: an observational study from the French national health data system.

Change in healthcare resource use and associated costs of patients with metastatic lung cancer between 2013 and 2021: an observational study from the French national health data system.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: October 21, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026